The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

They hope it will be approved by the Medicines and Healthcare Products Regulatory Agency to become the new standard of care.

Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to ...

The study found that patients with muscle-invasive bladder cancer had significantly less risk of cancer progressing or ...

A phase 3 clinical trial has shown that patients were 32 per cent less likely to experience cancer recurrence when treated ...

Neoadjuvant chemotherapy followed by transoral robotic surgery (NECTORS) and neck dissection led to better survival outcomes ...

A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...

Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with ...

Patients in the study with advanced bladder cancer had less risk of cancer progressing or returning when treated with ...

Tongue cancer (TC) cells can enter a chemo-resistant state by activating pathways related to autophagy and cholesterol synthesis, report researchers. Using a large-scale library of TC organoids they ...

Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage.